Hamilton Locke advises Little Green Pharma Ltd on its transformational merger with Cannatrek Ltd
Hamilton Locke is advising Little Green Pharma Ltd (ASX:LGP) on its proposed acquisition of 100% of the issued capital of Cannatrek Ltd by way of scheme of arrangement. Under the proposed merger, Cannatrek shareholders will receive scrip consideration in the form of new ordinary shares in Little Green Pharma plus contingent value shares. The contingent […]
